{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T22:28:20Z","timestamp":1784068100378,"version":"3.55.0"},"update-to":[{"DOI":"10.1371\/journal.pcbi.1013349","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T00:00:00Z","timestamp":1755043200000}}],"reference-count":87,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T00:00:00Z","timestamp":1754438400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"The National Key Research and Development Program of China","award":["2022YFA1004800"],"award-info":[{"award-number":["2022YFA1004800"]}]}],"content-domain":{"domain":["www.ploscompbiol.org"],"crossmark-restriction":false},"short-container-title":["PLoS Comput Biol"],"abstract":"<jats:p>Discovery of cancer driver pathways is essential for targeted therapies, since these pathways govern tumor progression and treatment resistance. However, their context-specific patterns across populations remain poorly understood. Leveraging pan-cancer genomic data, we apply our two models, EntCDP and ModSDP, to perform stratified analyses from four perspectives: region, tumor type, age group, and risk factors. Our results reveal the regional biases in perturbed pathways, such as PI3K-Akt in Chinese patients and GPCR in American patients with bladder cancer. Subtype comparisons highlight the mTOR signaling in lung adenocarcinoma and the FoxO signaling in lung squamous cell carcinoma. Pediatric-adult comparisons emphasize the enrichment of Ras signaling in pediatric acute myeloid leukemia and PAK signaling in pediatric glioblastoma, respectively. Risk factor associations further link Notch-mediated pathways to alcohol consumption and CDKN-regulated pathways to obesity-related cancers. Our findings demonstrate the utility of stratified driver pathway analysis in uncovering common and specific mechanisms, which can help prioritize context-aware therapeutic targets.<\/jats:p>","DOI":"10.1371\/journal.pcbi.1013349","type":"journal-article","created":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T17:43:39Z","timestamp":1754502219000},"page":"e1013349","update-policy":"https:\/\/doi.org\/10.1371\/journal.pcbi.corrections_policy","source":"Crossref","is-referenced-by-count":2,"title":["Multi-context modeling of driver pathways reveals common and specific mechanisms across 23 cancer types"],"prefix":"10.1371","volume":"21","author":[{"given":"Wenjia","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-4809-5446","authenticated-orcid":true,"given":"Junhua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,8,6]]},"reference":[{"issue":"20","key":"pcbi.1013349.ref001","doi-asserted-by":"crossref","first-page":"7697","DOI":"10.3390\/ijms21207697","article-title":"The Wnt signalling pathway: a tailored target in cancer","volume":"21","author":"M Koni","year":"2020","journal-title":"Int J Mol Sci."},{"issue":"9","key":"pcbi.1013349.ref002","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1200\/JCO.2016.71.0814","article-title":"Genomics, signaling, and treatment of Waldenstr\u00f6m macroglobulinemia","volume":"35","author":"ZR Hunter","year":"2017","journal-title":"J Clin Oncol."},{"issue":"7418","key":"pcbi.1013349.ref003","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/nature11412","article-title":"Comprehensive molecular portraits of human breast tumours","volume":"490","author":"Cancer Genome Atlas Network","year":"2012","journal-title":"Nature."},{"issue":"7793","key":"pcbi.1013349.ref004","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/s41586-020-1969-6","article-title":"Pan-cancer analysis of whole genomes","volume":"578","author":"ICGC\/TCGA Pan-Cancer Analysis of Whole Genomes Consortium","year":"2020","journal-title":"Nature."},{"issue":"5","key":"pcbi.1013349.ref005","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"E Cerami","year":"2012","journal-title":"Cancer Discov."},{"issue":"7467","key":"pcbi.1013349.ref006","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/nature12625","article-title":"The causes and consequences of genetic heterogeneity in cancer evolution","volume":"501","author":"RA Burrell","year":"2013","journal-title":"Nature."},{"issue":"11","key":"pcbi.1013349.ref007","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/s41568-019-0185-x","article-title":"An analysis of genetic heterogeneity in untreated cancers","volume":"19","author":"JG Reiter","year":"2019","journal-title":"Nat Rev Cancer."},{"issue":"6127","key":"pcbi.1013349.ref008","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1126\/science.1235122","article-title":"Cancer genome landscapes","volume":"339","author":"B Vogelstein","year":"2013","journal-title":"Science."},{"issue":"2","key":"pcbi.1013349.ref009","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/ng.3168","article-title":"Pan-cancer network analysis identifies combinations of rare somatic mutations across pathways and protein complexes","volume":"47","author":"MDM Leiserson","year":"2015","journal-title":"Nat Genet."},{"issue":"2","key":"pcbi.1013349.ref010","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1101\/gr.125567.111","article-title":"Mutual exclusivity analysis identifies oncogenic network modules","volume":"22","author":"G Ciriello","year":"2012","journal-title":"Genome Res."},{"issue":"2","key":"pcbi.1013349.ref011","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1101\/gr.120477.111","article-title":"De novo discovery of mutated driver pathways in cancer","volume":"22","author":"F Vandin","year":"2012","journal-title":"Genome Res."},{"issue":"22","key":"pcbi.1013349.ref012","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1093\/bioinformatics\/bts564","article-title":"Efficient methods for identifying mutated driver pathways in cancer","volume":"28","author":"J Zhao","year":"2012","journal-title":"Bioinformatics."},{"issue":"10","key":"pcbi.1013349.ref013","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkx089","article-title":"Discovery of cancer common and specific driver gene sets","volume":"45","author":"J Zhang","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"pcbi.1013349.ref014","article-title":"Pan-cancer study on transition of signaling systems from primary to metastatic tumors","author":"W Zhou","year":"2024","journal-title":"bioRxiv."},{"issue":"10","key":"pcbi.1013349.ref015","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/s41568-020-0290-x","article-title":"A compendium of mutational cancer driver genes","volume":"20","author":"F Mart\u00ednez-Jim\u00e9nez","year":"2020","journal-title":"Nat Rev Cancer."},{"key":"pcbi.1013349.ref016","doi-asserted-by":"crossref","first-page":"916400","DOI":"10.3389\/fgene.2022.916400","article-title":"Oncogenic signaling pathway dysregulation landscape reveals the role of pathways at multiple omics levels in pan-cancer","volume":"13","author":"N Wang","year":"2022","journal-title":"Front Genet."},{"key":"pcbi.1013349.ref017","doi-asserted-by":"crossref","unstructured":"Wu J, Pan K, Zhu K, Cai Q. Identifying Common Driver Pathways based on Pan-cancer Data. In: 2019 IEEE International Conference on Bioinformatics and Biomedicine (BIBM), 2019. p. 542\u20137. https:\/\/doi.org\/10.1109\/bibm47256.2019.8983414","DOI":"10.1109\/BIBM47256.2019.8983414"},{"key":"pcbi.1013349.ref018","doi-asserted-by":"crossref","first-page":"104010","DOI":"10.1016\/j.engappai.2020.104010","article-title":"Two novel models and a parthenogenetic algorithm for detecting common driver pathways from pan-cancer data","volume":"96","author":"J Wu","year":"2020","journal-title":"Engineering Applications of Artificial Intelligence."},{"key":"pcbi.1013349.ref019","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.semcdb.2017.05.023","article-title":"ROS signalling in the biology of cancer","volume":"80","author":"JN Moloney","year":"2018","journal-title":"Semin Cell Dev Biol."},{"issue":"3","key":"pcbi.1013349.ref020","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1517\/14728222.2013.749863","article-title":"Targeting IGF-1 signaling pathways in gynecologic malignancies","volume":"17","author":"I Bruchim","year":"2013","journal-title":"Expert Opin Ther Targets."},{"key":"pcbi.1013349.ref021","doi-asserted-by":"crossref","first-page":"605633","DOI":"10.3389\/fonc.2020.605633","article-title":"Adoptive cell therapy in breast cancer: a current perspective of next-generation medicine","volume":"10","author":"J Fuentes-Antras","year":"2020","journal-title":"Frontiers in Oncology."},{"issue":"2","key":"pcbi.1013349.ref022","doi-asserted-by":"crossref","first-page":"152750","DOI":"10.1016\/j.prp.2019.152750","article-title":"Giant cell tumor of soft tissue of the breast: case report with H3F3A mutation analysis and review of the literature","volume":"216","author":"T Luangxay","year":"2020","journal-title":"Pathol Res Pract."},{"issue":"8","key":"pcbi.1013349.ref023","doi-asserted-by":"crossref","first-page":"5415","DOI":"10.1111\/jcmm.14424","article-title":"Comprehensive epigenetic analyses reveal master regulators driving lung metastasis of breast cancer","volume":"23","author":"K Li","year":"2019","journal-title":"J Cell Mol Med."},{"issue":"4","key":"pcbi.1013349.ref024","doi-asserted-by":"crossref","DOI":"10.1186\/bcr2924","article-title":"Septin 9 isoform expression, localization and epigenetic changes during human and mouse breast cancer progression","volume":"13","author":"D Connolly","year":"2011","journal-title":"Breast Cancer Res."},{"issue":"8","key":"pcbi.1013349.ref025","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1080\/10408363.2019.1653821","article-title":"HGF\/MET pathway aberrations as diagnostic, prognostic, and predictive biomarkers in human cancers","volume":"56","author":"F Moosavi","year":"2019","journal-title":"Crit Rev Clin Lab Sci."},{"issue":"8","key":"pcbi.1013349.ref026","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1038\/modpathol.2017.33","article-title":"Next-generation sequencing-based molecular characterization of primary urinary bladder adenocarcinoma","volume":"30","author":"S Roy","year":"2017","journal-title":"Mod Pathol."},{"key":"pcbi.1013349.ref027","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.csbj.2019.12.014","article-title":"Deregulated bone morphogenetic proteins and their receptors are associated with disease progression of gastric cancer","volume":"18","author":"Z Sun","year":"2020","journal-title":"Comput Struct Biotechnol J."},{"key":"pcbi.1013349.ref028","doi-asserted-by":"crossref","first-page":"8079","DOI":"10.2147\/OTT.S248925","article-title":"miR-148a regulates the stem cell-like side populations distribution by affecting the expression of ACVR1 in esophageal squamous cell carcinoma","volume":"13","author":"Y Tan","year":"2020","journal-title":"Onco Targets Ther."},{"issue":"7","key":"pcbi.1013349.ref029","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.molmed.2019.04.012","article-title":"Abandoning the notion of non-small cell lung cancer","volume":"25","author":"V Relli","year":"2019","journal-title":"Trends Mol Med."},{"issue":"1","key":"pcbi.1013349.ref030","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s12964-019-0446-z","article-title":"Targeting PKCL-PAK1 signaling pathways in EGFR and KRAS mutant adenocarcinoma and lung squamous cell carcinoma","volume":"17","author":"M Ito","year":"2019","journal-title":"Cell Commun Signal."},{"issue":"2","key":"pcbi.1013349.ref031","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s10719-018-9815-x","article-title":"Biomolecular analysis of matrix proteoglycans as biomarkers in non small cell lung cancer","volume":"35","author":"MP Rangel","year":"2018","journal-title":"Glycoconj J."},{"key":"pcbi.1013349.ref032","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.2147\/DDDT.S249651","article-title":"Network pharmacology and experimental evidence reveal dioscin suppresses proliferation, invasion, and EMT via AKT\/GSK3b\/mTOR signaling in lung adenocarcinoma","volume":"14","author":"W Mao","year":"2020","journal-title":"Drug Des Devel Ther."},{"issue":"1","key":"pcbi.1013349.ref033","article-title":"KMT2D deficiency drives lung squamous cell carcinoma and hypersensitivity to RTK-RAS inhibition","volume":"41","author":"Y Pan","year":"2023","journal-title":"Cancer Cell."},{"issue":"4","key":"pcbi.1013349.ref034","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.jtho.2022.09.225","article-title":"Targeting NFE2L2\/KEAP1 mutations in advanced NSCLC with the TORC1\/2 inhibitor TAK-228","volume":"18","author":"PK Paik","year":"2023","journal-title":"Journal of Thoracic Oncology."},{"issue":"1","key":"pcbi.1013349.ref035","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13293-020-00291-x","article-title":"Sex differences in cancer mechanisms","volume":"11","author":"JB Rubin","year":"2020","journal-title":"Biol Sex Differ."},{"issue":"5","key":"pcbi.1013349.ref036","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1136\/ijgc-00009577-200409000-00002","article-title":"Common risk factors of breast and ovarian cancer: recent view","volume":"14","author":"GC Zografos","year":"2004","journal-title":"Int J Gynecol Cancer."},{"issue":"6","key":"pcbi.1013349.ref037","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1124\/mol.118.115279","article-title":"The role of ACKR3 in breast, lung, and brain cancer","volume":"96","author":"M Neves","year":"2019","journal-title":"Mol Pharmacol."},{"issue":"8","key":"pcbi.1013349.ref038","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.3390\/biom11081211","article-title":"GNAi2\/gip2-regulated transcriptome and its therapeutic significance in ovarian cancer","volume":"11","author":"JH Ha","year":"2021","journal-title":"Biomolecules."},{"issue":"16","key":"pcbi.1013349.ref039","doi-asserted-by":"crossref","first-page":"4268","DOI":"10.1158\/0008-5472.CAN-16-2224","article-title":"EIF1AX and NRAS mutations co-occur and cooperate in low-grade serous ovarian carcinomas","volume":"77","author":"D Etemadmoghadam","year":"2017","journal-title":"Cancer Res."},{"issue":"10","key":"pcbi.1013349.ref040","article-title":"Transcriptional repression of p21 by EIF1AX promotes the proliferation of breast cancer cells","volume":"53","author":"Y Li","year":"2020","journal-title":"Cell Prolif."},{"issue":"1","key":"pcbi.1013349.ref041","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12964-019-0486-4","article-title":"FGFR3 signaling and function in triple negative breast cancer","volume":"18","author":"NJ Chew","year":"2020","journal-title":"Cell Commun Signal."},{"issue":"1","key":"pcbi.1013349.ref042","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1038\/s41467-020-16199-4","article-title":"Targeting lysyl oxidase (LOX) overcomes chemotherapy resistance in triple negative breast cancer","volume":"11","author":"O Saatci","year":"2020","journal-title":"Nat Commun."},{"issue":"12","key":"pcbi.1013349.ref043","article-title":"The prognostic value of the lysyl oxidase family in ovarian cancer","volume":"34","author":"M Ye","year":"2020","journal-title":"J Clin Lab Anal."},{"issue":"4","key":"pcbi.1013349.ref044","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3727\/105221615X14399878166113","article-title":"GATA3 in breast cancer: tumor suppressor or oncogene?","volume":"16","author":"M Takaku","year":"2015","journal-title":"Gene Expr."},{"key":"pcbi.1013349.ref045","doi-asserted-by":"crossref","first-page":"109539","DOI":"10.1016\/j.cellsig.2020.109539","article-title":"GATA3 as a master regulator for interactions of tumor-associated macrophages with high-grade serous ovarian carcinoma","volume":"68","author":"AA El-Arabey","year":"2020","journal-title":"Cell Signal."},{"issue":"5","key":"pcbi.1013349.ref046","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s12282-020-01091-2","article-title":"Rac1 activation in human breast carcinoma as a prognostic factor associated with therapeutic resistance","volume":"27","author":"M Yamaguchi","year":"2020","journal-title":"Breast Cancer."},{"issue":"10","key":"pcbi.1013349.ref047","doi-asserted-by":"crossref","first-page":"358","DOI":"10.3390\/cancers10100358","article-title":"Ovarian tumor microenvironment signaling: convergence on the Rac1 GTPase","volume":"10","author":"LG Hudson","year":"2018","journal-title":"Cancers (Basel)."},{"issue":"7","key":"pcbi.1013349.ref048","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1172\/JCI67428","article-title":"CD4+ follicular helper T cell infiltration predicts breast cancer survival","volume":"123","author":"C Gu-Trantien","year":"2013","journal-title":"J Clin Invest."},{"issue":"1","key":"pcbi.1013349.ref049","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12906-019-2780-5","article-title":"Cordyceps militaris induces apoptosis in ovarian cancer cells through TNF-\u03b1\/TNFR1-mediated inhibition of NF-\u03baB phosphorylation","volume":"20","author":"E Jo","year":"2020","journal-title":"BMC Complement Med Ther."},{"issue":"4","key":"pcbi.1013349.ref050","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2015-1241","article-title":"Case report of spontaneous resolution of a congenital glioblastoma","volume":"137","author":"T Davis","year":"2016","journal-title":"Pediatrics."},{"issue":"1","key":"pcbi.1013349.ref051","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12943-016-0571-x","article-title":"Targeting acute myeloid leukemia stem cell signaling by natural products","volume":"16","author":"KS Siveen","year":"2017","journal-title":"Mol Cancer."},{"issue":"47","key":"pcbi.1013349.ref052","doi-asserted-by":"crossref","first-page":"6738","DOI":"10.1038\/sj.onc.1210758","article-title":"Aberrant cytokine signaling in leukemia","volume":"26","author":"RA Van Etten","year":"2007","journal-title":"Oncogene."},{"issue":"7","key":"pcbi.1013349.ref053","doi-asserted-by":"crossref","first-page":"715","DOI":"10.3390\/cells8070715","article-title":"Fibroblast growth factor receptor functions in glioblastoma","volume":"8","author":"A Jimenez-Pascual","year":"2019","journal-title":"Cells."},{"issue":"4","key":"pcbi.1013349.ref054","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1124\/pr.114.009217","article-title":"Phospholipase D signaling pathways and phosphatidic acid as therapeutic targets in cancer","volume":"66","author":"RC Bruntz","year":"2014","journal-title":"Pharmacol Rev."},{"issue":"9","key":"pcbi.1013349.ref055","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1038\/s41375-024-02340-5","article-title":"PHF6 suppresses self-renewal of leukemic stem cells in AML","volume":"38","author":"SS Jalnapurkar","year":"2024","journal-title":"Leukemia."},{"issue":"2","key":"pcbi.1013349.ref056","first-page":"60","article-title":"ASXL1 gene in AML","volume":"47","author":"R Hurtado","year":"2021","journal-title":"J Assoc Genet Technol."},{"issue":"8","key":"pcbi.1013349.ref057","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.3390\/ijms21082907","article-title":"The PI3K-Akt-mTOR signaling pathway in human acute myeloid leukemia (AML) cells","volume":"21","author":"I Nepstad","year":"2020","journal-title":"Int J Mol Sci."},{"issue":"1","key":"pcbi.1013349.ref058","doi-asserted-by":"crossref","first-page":"12485","DOI":"10.1038\/s41598-021-91864-2","article-title":"Meta-analysis of gene signatures and key pathways indicates suppression of JNK pathway as a regulator of chemo-resistance in AML","volume":"11","author":"P Modarres","year":"2021","journal-title":"Sci Rep."},{"issue":"22","key":"pcbi.1013349.ref059","doi-asserted-by":"crossref","first-page":"33440","DOI":"10.18632\/oncotarget.7961","article-title":"PI3K\/Akt\/mTOR signaling pathway and targeted therapy for glioblastoma","volume":"7","author":"X Li","year":"2016","journal-title":"Oncotarget."},{"issue":"24","key":"pcbi.1013349.ref060","doi-asserted-by":"crossref","first-page":"10300","DOI":"10.1158\/0008-5472.CAN-08-3272","article-title":"Mutational inactivation of PTPRD in glioblastoma multiforme and malignant melanoma","volume":"68","author":"DA Solomon","year":"2008","journal-title":"Cancer Res."},{"issue":"3","key":"pcbi.1013349.ref061","doi-asserted-by":"crossref","first-page":"583","DOI":"10.3324\/haematol.2020.269431","article-title":"Clinical significance of RAS pathway alterations in pediatric acute myeloid leukemia","volume":"107","author":"T Kaburagi","year":"2022","journal-title":"Haematologica."},{"issue":"5","key":"pcbi.1013349.ref062","doi-asserted-by":"crossref","DOI":"10.1111\/ajco.13367","article-title":"Genetic aberrations involved in relapse of pediatric acute myeloid leukemia: a literature review","volume":"17","author":"N Zafar","year":"2021","journal-title":"Asia Pac J Clin Oncol."},{"issue":"3","key":"pcbi.1013349.ref063","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1053\/j.seminoncol.2009.03.007","article-title":"Acute leukemia in adolescents and young adults","volume":"36","author":"AS Advani","year":"2009","journal-title":"Semin Oncol."},{"issue":"10","key":"pcbi.1013349.ref064","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1038\/s41375-018-0102-4","article-title":"RET-mediated autophagy suppression as targetable co-dependence in acute myeloid leukemia","volume":"32","author":"S Rudat","year":"2018","journal-title":"Leukemia."},{"key":"pcbi.1013349.ref065","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3389\/fped.2019.00067","article-title":"Long noncoding RNAs: emerging players in medulloblastoma","volume":"7","author":"P Laneve","year":"2019","journal-title":"Frontiers in Pediatrics."},{"issue":"10","key":"pcbi.1013349.ref066","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1007\/s00381-015-2735-1","article-title":"Uncommon pediatric tumors of the posterior fossa: pathologic and molecular features","volume":"31","author":"C Dunham","year":"2015","journal-title":"Childs Nerv Syst."},{"issue":"2","key":"pcbi.1013349.ref067","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s00441-018-2796-z","article-title":"Origin and initiation mechanisms of neuroblastoma","volume":"372","author":"S Tsubota","year":"2018","journal-title":"Cell Tissue Res."},{"issue":"5","key":"pcbi.1013349.ref068","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1002\/mc.23176","article-title":"EGFR-ERK pathway regulates CSN6 to contribute to PD-L1 expression in glioblastoma","volume":"59","author":"L Su","year":"2020","journal-title":"Mol Carcinog."},{"issue":"5","key":"pcbi.1013349.ref069","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20200723","article-title":"Long non-coding RNA SNHG16 regulates cell behaviors through miR-542-3p\/HNF4\u03b1 axis via RAS\/RAF\/MEK\/ERK signaling pathway in pediatric neuroblastoma cells","volume":"40","author":"D Deng","year":"2020","journal-title":"Biosci Rep."},{"issue":"2","key":"pcbi.1013349.ref070","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1136\/tobaccocontrol-2020-056444","article-title":"Smoking-related cancer death among men and women in an ageing society (China 2020-2040): a population-based modelling study","volume":"32","author":"N Li","year":"2023","journal-title":"Tob Control."},{"issue":"11","key":"pcbi.1013349.ref071","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1038\/s41588-021-00928-6","article-title":"Mutational signatures in esophageal squamous cell carcinoma from eight countries with varying incidence","volume":"53","author":"S Moody","year":"2021","journal-title":"Nat Genet."},{"issue":"22","key":"pcbi.1013349.ref072","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1056\/NEJMoa1616288","article-title":"Tracking the evolution of non-small-cell lung cancer","volume":"376","author":"M Jamal-Hanjani","year":"2017","journal-title":"N Engl J Med."},{"issue":"4","key":"pcbi.1013349.ref073","doi-asserted-by":"crossref","first-page":"300060519897215","DOI":"10.1177\/0300060519897215","article-title":"Exploring potential biomarkers for lung adenocarcinoma using LC-MS\/MS metabolomics","volume":"48","author":"L Mo","year":"2020","journal-title":"J Int Med Res."},{"issue":"9","key":"pcbi.1013349.ref074","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1038\/s41588-021-00920-0","article-title":"Genomic and evolutionary classification of lung cancer in never smokers","volume":"53","author":"T Zhang","year":"2021","journal-title":"Nat Genet."},{"key":"pcbi.1013349.ref075","doi-asserted-by":"crossref","first-page":"100163","DOI":"10.1074\/jbc.RA120.015352","article-title":"Direct evidence that the GPCR CysLTR2 mutant causative of uveal melanoma is constitutively active with highly biased signaling","volume":"296","author":"E Ceraudo","year":"2021","journal-title":"J Biol Chem."},{"issue":"12","key":"pcbi.1013349.ref076","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1093\/jnci\/djy060","article-title":"Tobacco smoking-associated alterations in the immune microenvironment of squamous cell carcinomas","volume":"110","author":"A Desrichard","year":"2018","journal-title":"J Natl Cancer Inst."},{"issue":"6","key":"pcbi.1013349.ref077","doi-asserted-by":"crossref","DOI":"10.3390\/ma15062086","article-title":"Insights into nanomedicine for head, neck cancer diagnosis and treatment","volume":"15","author":"C Viegas","year":"2086","journal-title":"Materials"},{"issue":"1","key":"pcbi.1013349.ref078","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1515\/med-2020-0114","article-title":"CCTs as new biomarkers for the prognosis of head and neck squamous cancer","volume":"15","author":"Y Dong","year":"2020","journal-title":"Open Med (Wars)."},{"issue":"9","key":"pcbi.1013349.ref079","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.3727\/096504019X15579146061957","article-title":"Profilin 2 promotes proliferation and metastasis of head and neck cancer cells by regulating PI3K\/AKT\/\u03b2-catenin signaling pathway","volume":"27","author":"K Zhou","year":"2019","journal-title":"Oncol Res."},{"issue":"4","key":"pcbi.1013349.ref080","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1002\/hed.26023","article-title":"Alcohol-related head and neck cancer: summary of the literature","volume":"42","author":"A Marziliano","year":"2020","journal-title":"Head Neck."},{"key":"pcbi.1013349.ref081","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/164_2017_76","article-title":"Presynaptic ethanol actions: potential roles in ethanol seeking","volume":"248","author":"DM Lovinger","year":"2018","journal-title":"Handb Exp Pharmacol."},{"issue":"2","key":"pcbi.1013349.ref082","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.ajpath.2010.10.027","article-title":"Antigen presentation and MHC class II expression by human esophageal epithelial cells: role in eosinophilic esophagitis","volume":"178","author":"DJ Mulder","year":"2011","journal-title":"Am J Pathol."},{"issue":"8","key":"pcbi.1013349.ref083","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1056\/NEJMsr1606602","article-title":"Body Fatness and Cancer\u2013Viewpoint of the IARC Working Group","volume":"375","author":"B Lauby-Secretan","year":"2016","journal-title":"N Engl J Med."},{"issue":"1","key":"pcbi.1013349.ref084","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1749-6632.2012.06750.x","article-title":"Obesity and cancer risk: evidence, mechanisms, and recommendations","volume":"1271","author":"I Vucenik","year":"2012","journal-title":"Ann N Y Acad Sci."},{"issue":"8","key":"pcbi.1013349.ref085","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1515\/hsz-2017-0118","article-title":"Chronic viral hepatitis and its association with liver cancer","volume":"398","author":"T Tu","year":"2017","journal-title":"Biol Chem."},{"issue":"2","key":"pcbi.1013349.ref086","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1007\/s10350-004-0777-7","article-title":"Yersinia enterocolitica infection in a patient with hemachromatosis masquerading as proximal colon cancer with liver metastases: report of a case","volume":"48","author":"J Crosbie","year":"2005","journal-title":"Dis Colon Rectum."},{"key":"pcbi.1013349.ref087","article-title":"DAVID: a web server for functional enrichment analysis and functional annotation of gene lists 2021 update","volume":"50","author":"BT Sherman","year":"2022","journal-title":"). Nucleic Acids Research."}],"updated-by":[{"DOI":"10.1371\/journal.pcbi.1013349","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T00:00:00Z","timestamp":1755043200000}}],"container-title":["PLOS Computational Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1013349","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T18:46:23Z","timestamp":1755110783000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1013349"}},"subtitle":[],"editor":[{"given":"Melissa L.","family":"Kemp","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,8,6]]},"references-count":87,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,8,6]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pcbi.1013349","relation":{"new_version":[{"id-type":"doi","id":"10.1371\/journal.pcbi.1013349","asserted-by":"object"}]},"ISSN":["1553-7358"],"issn-type":[{"value":"1553-7358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,6]]}}}